Page 1 of Clinical Trials for Drug Rifampin, 185 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Withdrawn
Interplay Between Organic Anion Transporting Polypeptide (OATP) Transporters Transporters and CYP2C9 in Glyburide Pharmacokinetics (PK)
Last Updated: February 22, 2011
Condition(s): Healthy
2
Active, not recruiting
Sulforaphane as an Antagonist to Human PXR-mediated Drug-drug Interactions
Last Updated: November 12, 2009
Condition(s): Adverse Drug Interactions
3
Completed
TMC435350-TiDP16-C105: Phase I, 3-way Crossover, Drug-drug Interaction Between TMC435350 and Rifampin After Multiple Dosing.
Last Updated: April 26, 2010
Condition(s): Hepatitis C; HCV; Tuberculosis; Rifampin; Pharmacokinetics
4
Completed
A Bioequivalence Study Comparing A Fixed Dose Combination Formulation Of Myrin P Forte That Contains Rifampicin, Isoniazid, Ethambutol And Pyrazinamide Per Tablet To An Equivalent Dose Of Single Drug Reference Preparations Of Similar Combination Following Oral Administration In Healthy Adults
Last Updated: August 30, 2011
Condition(s): Healthy Volunteers
5
Completed
Drug Interaction Study of Rifampin and Warfarin in Healthy Volunteers.
Last Updated: June 6, 2011
Condition(s): Healthy
6
Active, not recruiting
Randomized Clinical Trial of 4RIF vs. 9INH for the Treatment of Latent TB - Safety
Last Updated: July 22, 2011
Condition(s): Latent Tuberculosis Infection
7
Completed
Nevirapine Drug Levels in HIV Positive Patients Also Receiving Rifampicin for Tuberculosis
Last Updated: December 3, 2010
Condition(s): HIV Infections; Tuberculosis
8
Not yet recruiting
Trial of High-Dose Rifampin in Patients With TB
Last Updated: August 2, 2011
Condition(s): Tuberculosis
9
Active, not recruiting
Drug Interaction Between Coartem® and Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients
Last Updated: December 3, 2010
Condition(s): HIV Infections; Tuberculosis
10
Recruiting
Anti-tuberculosis (TB) Drug Levels and Correlation With Drug Induced Hepatotoxicity
Last Updated: October 20, 2011
Condition(s): Hepatitis; Tuberculosis
11
Completed
A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.
Last Updated: March 11, 2011
Condition(s): Mycobacterium Avium-intracellulare Infection; HIV Infections
12
Completed
Bioequivalence Study Comparing Rifampicin In A Fixed-Dose Combination (Rifampicin+Isoniazid, Myrin© 2) And The Reference Drug (Rifampicin, Rimactane®)
Last Updated: June 9, 2011
Condition(s): Tuberculosis
13
Active, not recruiting
Interaction of Buprenorphine With HIV Medications and Tuberculosis Medications
Last Updated: September 15, 2011
Condition(s): Opioid Dependency; HIV Infections
14
Completed
Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected Adults
Last Updated: August 6, 2009
Condition(s): HIV Infections; Tuberculosis
15
Completed
Drug-Drug Interaction Study With Rifampin
Last Updated: January 24, 2011
Condition(s): Alzheimer Disease
16
Recruiting
Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary Tuberculosis
Last Updated: January 27, 2012
Condition(s): Pulmonary Tuberculosis
17
Completed
Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis
Last Updated: March 1, 2011
Condition(s): HIV Infections; Tuberculosis
18
Completed
Drug Interaction Study With Rifampicin and Afatinib
Last Updated: February 8, 2012
Condition(s): Healthy
19
Completed
Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection
Last Updated: February 28, 2011
Condition(s): HIV Infections; Tuberculosis
20
Enrolling by invitation
Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35)
Last Updated: January 30, 2012
Condition(s): Carcinomas; Disease, Hodgkin; Lymphoma, Large-Cell, Anaplastic; Lymphoma, Non-Hodgkin; Neoplasms

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://www.clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Rifampin

Page 1 of Clinical Trials for Drug Rifampin, 185 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About